FDA MedWatch Safety AlertsUnited States9 October 2026
Par Health Issues Voluntary Nationwide Recall of Two Lots of Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) Due to the Presence of Particulate Matter
This is an official announcement record
Firsthand records what FDA MedWatch Safety Alerts announced and links to the original. The wording below is theirs, not ours.
FOR IMMEDIATE RELEASE - ROCHESTER, MI– October 8, 2026 –Par Health is voluntarily recalling two lots of Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) to the hospital level. The product is being recalled due to the presence of particulate matter identified as cellulose.
Read the official announcement
Opens www.fda.gov
More from FDA MedWatch Safety Alerts
- Nova Biomedical® Announces Global Medical Device Correction for StatStrip® Glucose Hospital Meter6 October 2026
- IV Tubing Set Correction: ICU Medical Updates Use Instructions for IV Tubing Sets5 October 2026
- Infusion Set Recall: BD and CareFusion 303, Inc. Remove BD Alaris Pump Infusion Sets5 October 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program — especially if you are pregnant, nursing, taking medication, or managing a health condition.